- Home
- CREV vs SNTI Comparison
CREV vs SNTI Comparison
Compare CREV & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- SNTI
- Stock Information
- Founded
- CREV 2007
- SNTI 2016
- Country
- CREV Ireland
- SNTI United States
- Employees
- CREV N/A
- SNTI N/A
- Industry
- CREV
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- CREV
- SNTI Health Care
- Exchange
- CREV Nasdaq
- SNTI Nasdaq
- Market Cap
- CREV 8.8M
- SNTI 10.4M
- IPO Year
- CREV N/A
- SNTI N/A
- Fundamental
- Price
- CREV $2.99
- SNTI $2.15
- Analyst Decision
- CREV Strong Buy
- SNTI
- Analyst Count
- CREV 1
- SNTI 0
- Target Price
- CREV $39.00
- SNTI N/A
- AVG Volume (30 Days)
- CREV 58.6K
- SNTI 15.8K
- Earning Date
- CREV 01-01-0001
- SNTI 11-26-2024
- Dividend Yield
- CREV N/A
- SNTI N/A
- EPS Growth
- CREV N/A
- SNTI N/A
- EPS
- CREV N/A
- SNTI N/A
- Revenue
- CREV $39,261,077.00
- SNTI $338,000.00
- Revenue This Year
- CREV $40.76
- SNTI $254.47
- Revenue Next Year
- CREV $86.18
- SNTI $169.66
- P/E Ratio
- CREV N/A
- SNTI N/A
- Revenue Growth
- CREV 41.52
- SNTI N/A
- 52 Week Low
- CREV $2.61
- SNTI $1.52
- 52 Week High
- CREV $46.00
- SNTI $7.43
- Technical
- Relative Strength Index (RSI)
- CREV 34.46
- SNTI 44.66
- Support Level
- CREV $3.02
- SNTI $2.12
- Resistance Level
- CREV $4.53
- SNTI $2.40
- Average True Range (ATR)
- CREV 0.46
- SNTI 0.16
- MACD
- CREV 0.02
- SNTI 0.02
- Stochastic Oscillator
- CREV 19.80
- SNTI 13.98
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.